A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
2017) PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations, Drug Delivery, 24:1, 339-345, Abstract In this study, PCM and TAT co-modified liposome was developed as a novel drug carrier for myocardium delivery with evaluation of its in vitro and in vivo properties. Liposomes containing fluorescent probe coumarin-6 were prepared by thin-film hydration. The PCM ligands specifically bind to the PCM receptors in the extracellular connective tissue ofdoi:10.1080/10717544.2016.1253121 pmid:28165817 fatcat:i7dy3ogujnhbla57sch5i7nnlm